Page 8 of 11 – SEC Filing The
following constitutes Amendment No. 4 (Amendment No. 4) to the Schedule 13D.
Amendment No. 4 amends the Schedule 13D as specifically set forth herein.
ITEM 3. SOURCE AND
AMOUNT OF FUNDS OR OTHER CONSIDERATION.
Item
3 is hereby amended and restated as follows:
The
purchases of the shares of Common Stock reported herein were made using the
general investment funds of the Reporting Persons. The amount of funds used for
all purchases of Common Stock of the Issuer by the Reporting Persons covered by
this report was an aggregate of $62,152,834.
To
the best of the Reporting Persons knowledge, none of the persons listed on
Appendix A beneficially owns any securities of the Issuer.
ITEM 5. INTEREST IN
SECURITIES OF THE ISSUER.
Item
5 is hereby amended and restated as follows:
(a)
As of the close of business on June 16, 2016, Trilogy beneficially owned 370,963
shares of Common Stock (of which 82,114,218 shares are currently issued and
outstanding, according to information provided by the Issuer), constituting less
than 1.0% of the issued and outstanding shares of Common Stock. As of the close
of business on May 24, 2016, Levcap beneficially owned 65,584 shares of Common
Stock, constituting less than 1.0% of the issued and outstanding shares of
Common Stock. As the general partner of Trilogy, LCSL may be deemed to
beneficially own the 370,963 shares of Common Stock owned by Trilogy. As the
general partner of Levcap, LCSEP may be deemed to beneficially own the 65,584
shares of Common Stock owned by Levcap.
As of the close of business on June 16, 2016, LCS may be deemed to beneficially
own 3,360,860 shares of Common Stock, constituting approximately 4.1% of the
issued and outstanding shares of Common Stock, which includes: (i) 370,963
shares of Common Stock beneficially owned by Trilogy, by virtue of serving as
Trilogys investment advisor, (ii) 65,584 shares of Common Stock beneficially
owned by Levcap, by virtue of serving as Levcaps investment advisor, (iii)
370,963 shares of Common Stock as a result of acting as sub-investment advisor
to certain investment companies, as further described in clause (d) below, and
(iv) 2,816,489 shares held in managed accounts for whom LCS acts as investment
manager.
As of the close of business on June 16, 2016, Levin may be deemed to
beneficially own 4,056,731 shares of Common Stock, constituting approximately
4.9% of the issued and outstanding shares of Common Stock, which includes: (i)
3,059,169 shares of Common Stock that may be deemed to be beneficially owned by
LCS, by virtue of serving as the Managing Member and Chief Executive Officer of
LCS and the managing member of each of LCSL and LCSEP, (ii) 259,324 shares of
Common Stock which are held in trust accounts for the benefit of his wife and
children of which he controls, and (iii) 738,238 shares of Common Stock which
are held in managed accounts owned by various family members of Levin, of which
he has shared voting and dispositive power over.
The filing of this Schedule 13D shall not be construed as an admission that the
Reporting Persons are, for purposes of Section 13(d) of the Securities Exchange
Act of 1934, as amended, the beneficial owners of any of the securities reported
herein. Each of the Reporting Persons specifically disclaims beneficial
ownership of the securities reported herein that are not directly owned by such
Reporting Person, except to the extent of their pecuniary interest therein.
To
the best of the Reporting Persons knowledge, none of the persons listed on
Appendix A beneficially owns any securities of the Issuer.
(b)
Trilogy, LCSL, LCS and Levin may be deemed to have shared voting and dispositive
power over the 370,963 shares of Common Stock Trilogy beneficially owns. Levcap,
LCSEP, LCS, Levin and the portfolio manager of Levcap, may be deemed to have
shared voting and dispositive power over the 65,584 shares of Common Stock
Levcap beneficially owns
The
following constitutes Amendment No. 4 (Amendment No. 4) to the Schedule 13D.
Amendment No. 4 amends the Schedule 13D as specifically set forth herein.
ITEM 3. SOURCE AND
AMOUNT OF FUNDS OR OTHER CONSIDERATION.
Item
3 is hereby amended and restated as follows:
The
purchases of the shares of Common Stock reported herein were made using the
general investment funds of the Reporting Persons. The amount of funds used for
all purchases of Common Stock of the Issuer by the Reporting Persons covered by
this report was an aggregate of $62,152,834.
To
the best of the Reporting Persons knowledge, none of the persons listed on
Appendix A beneficially owns any securities of the Issuer.
ITEM 5. INTEREST IN
SECURITIES OF THE ISSUER.
Item
5 is hereby amended and restated as follows:
(a)
As of the close of business on June 16, 2016, Trilogy beneficially owned 370,963
shares of Common Stock (of which 82,114,218 shares are currently issued and
outstanding, according to information provided by the Issuer), constituting less
than 1.0% of the issued and outstanding shares of Common Stock. As of the close
of business on May 24, 2016, Levcap beneficially owned 65,584 shares of Common
Stock, constituting less than 1.0% of the issued and outstanding shares of
Common Stock. As the general partner of Trilogy, LCSL may be deemed to
beneficially own the 370,963 shares of Common Stock owned by Trilogy. As the
general partner of Levcap, LCSEP may be deemed to beneficially own the 65,584
shares of Common Stock owned by Levcap.
As of the close of business on June 16, 2016, LCS may be deemed to beneficially
own 3,360,860 shares of Common Stock, constituting approximately 4.1% of the
issued and outstanding shares of Common Stock, which includes: (i) 370,963
shares of Common Stock beneficially owned by Trilogy, by virtue of serving as
Trilogys investment advisor, (ii) 65,584 shares of Common Stock beneficially
owned by Levcap, by virtue of serving as Levcaps investment advisor, (iii)
370,963 shares of Common Stock as a result of acting as sub-investment advisor
to certain investment companies, as further described in clause (d) below, and
(iv) 2,816,489 shares held in managed accounts for whom LCS acts as investment
manager.
As of the close of business on June 16, 2016, Levin may be deemed to
beneficially own 4,056,731 shares of Common Stock, constituting approximately
4.9% of the issued and outstanding shares of Common Stock, which includes: (i)
3,059,169 shares of Common Stock that may be deemed to be beneficially owned by
LCS, by virtue of serving as the Managing Member and Chief Executive Officer of
LCS and the managing member of each of LCSL and LCSEP, (ii) 259,324 shares of
Common Stock which are held in trust accounts for the benefit of his wife and
children of which he controls, and (iii) 738,238 shares of Common Stock which
are held in managed accounts owned by various family members of Levin, of which
he has shared voting and dispositive power over.
The filing of this Schedule 13D shall not be construed as an admission that the
Reporting Persons are, for purposes of Section 13(d) of the Securities Exchange
Act of 1934, as amended, the beneficial owners of any of the securities reported
herein. Each of the Reporting Persons specifically disclaims beneficial
ownership of the securities reported herein that are not directly owned by such
Reporting Person, except to the extent of their pecuniary interest therein.
To
the best of the Reporting Persons knowledge, none of the persons listed on
Appendix A beneficially owns any securities of the Issuer.
(b)
Trilogy, LCSL, LCS and Levin may be deemed to have shared voting and dispositive
power over the 370,963 shares of Common Stock Trilogy beneficially owns. Levcap,
LCSEP, LCS, Levin and the portfolio manager of Levcap, may be deemed to have
shared voting and dispositive power over the 65,584 shares of Common Stock
Levcap beneficially owns
